Antibacterial and cytotoxic metabolites produced by Streptomyces tanashiensis BYF-112 isolated from Odontotermes formosanus

Abstract

Chemical investigations of the termite-associated Streptomyces tanashiensis BYF-112 resulted in the discovery of four novel alkaloid derivatives: vegfrecines A and B (1 and 2), exfoliazone A (3), and venezueline H (7), in addition to nine known metabolites (4−6, 8−13). The structures of these compounds were elucidated through comprehensive spectroscopic analysis and comparison with existing literature data. Antibacterial assays revealed that viridomycin A (11) exhibited potent antibacterial activity against Staphylococcus aureus, with a zone of inhibition (ZOI) of 12.67 mm, in comparison to a ZOI of 17.67 mm for the positive control gentamicin sulfate. Viridomycin A (11) showed moderate activity against Micrococcus tetragenus and Pseudomonas syringae pv. actinidae, with ZOI values of 15.50 and 14.33 mm, respectively, which were inferior to those of gentamicin sulfate (34.67 and 24.00 mm). Viridomycin F (12) also exhibited moderate antibacterial effects against S. aureus, M. tetragenus, and P. syringae pv. actinidae, with ZOI values of 8.33, 16.50, and 10.83 mm, respectively. Cytotoxicity assays demonstrated that viridobruunine A (5), exfoliazone (6), viridomycin A (11), and X-14881E (13) exhibited significant cytotoxicity against human malignant melanoma (A375), ovarian cancer (SKOV-3), and gastric cancer (MGC-803) cell lines, with IC₅₀ values ranging from 4.61 to 19.28 μmol·L⁻¹. Furthermore, bioinformatic analysis of the complete genome of S. tanashiensis suggested a putative biosynthetic gene cluster (BGC) responsible for the production of compounds 1−12. These findings indicate that the secondary metabolites of insect-associated S. tanashiensis BYF-112 hold promise as potential sources of novel antibacterial and anticancer agents.

Keywords

Odontotermes formosanus / Streptomyces tanashiensis / Alkaloid / Cytotoxic activity / Antibacterial activity / Biosynthetic pathway

References

[1] Hug JJ, Bader CD, Remškar M, et al. Concepts and methods to access novel antibiotics from Actinomycetes[J]. J Antibiotics, 2018, 7: 44.

[2] Zhang YL, Ge HM, Li F, et al. New phytotoxic metabolites from Pestalotiopsis sp. HC02, a fungus residing in Chondracris rosee gut[J]. Chem Biodivers, 2008, 5: 2402-2407.

[3] Eggleton P. The state of the world’s insects[J]. Ann Rev Envi and Res, 2020, 45(1): 61-82.

[4] Gosalbes MJ, Latorre A, Lamelas A, et al. Genomics of intracellular symbionts in insects[J]. J Med Microbiol, 2010, 300: 271-278.

[5] Van Arnam EB, Ruzzini AC, Sit CS, et al. Selvamicin, an atypical antifungal polyene from two alternative genomic contexts[J]. Pro Natl Acad Sci USA, 2016, 113: 12940-12945.

[6] Zhang AH, Liu W, Jiang N, et al. Sequestration of guest intermediates by dalesconol bioassembly lines in Daldinia eschscholzii[J]. Org Lett, 2017, 19: 2142-2145.

[7] Beemelmanns C, Ramadhar TR, Kim KH, et al. Macrotermycins A-D, glycosylated macrolactams from a termite-associated Amycolatopsis sp. M39[J]. Org Lett, 2017, 19: 1000-1003.

[8] Zhang YL, Zhang J, Jiang N, et al. Immunosuppressive polyketides from the mantis-associated Daldinia eschscholzii[J]. J Am Chem Soc, 2011, 133: 5931-5940.

[9] Ma SY, Xiao YS, Zhang B, et al. Amycolamycins A and B, two enediyne-derived compounds from a locust-associated Actinomycete[J]. Org Lett, 2017, 19(22): 6208-6211.

[10] Qin ZW, Munnoch JT, Devine R, et al. Formicamycins, antibacterial polyketides produced by Streptomyces formicae isolated from African Tetraponera plant-ants[J]. Chem Sci, 2017, 8(4): 3218-3227.

[11] Li S, Shao MW, Lu YH, et al. Phytotoxic and antibacterial metabolites from Fusarium proliferatum ZS07 isolated from the gut of long-horned grasshoppers[J]. J Agr Food Chem, 2014, 62: 8997-9001.

[12] Long YH, Zhang Y, Huang F, et al. Diversity and antimicrobial activities of culturable actinomycetes from Odontotermes formosanus (Blattaria: Termitidae)[J]. BMC Microbiol, 2022, 22(1): 80.

[13] Zhang SX, Wu J, Jiang Z, et al. Pigments of aminophenoxazinones and viridomycins produced by termite-associated Streptomyces tanashiensis BYF-112[J]. Front. Microbiol, 2023, 13: 1110811.

[14] Nosaka C, Adachi H, Sawa R, et al. Vegfrecine, an inhibitor of vegf receptor tyrosine kinases isolated from the culture broth of Streptomyces sp.[J]. J Nat Prod, 2013, 76: 715-719.

[15] Imai S, Shimazu A, Furihata K, et al. Isolation and structure of a new phenoxazine antibiotic, exfoliazone, produced by Streptomyces exfoliates[J]. J Antibiotics, 1990, 43: 1606-1607.

[16] Gerber NN, Yale HL, Taber WA, et al. Structure and syntheses of texazone, 2-(N-methylamino)-3H-phenoxazin-3-one-8-carboxylic acid, an actinomycete metabolite[J]. J Antibiotics, 1983, 36(6): 688-694.

[17] Zhang XM, Liu X, Wang Z, et al. ChemInform abstract: viridobrunnines A and B, antimicrobial phenoxazinone alkaloids from a soil associated Streptomyces sp.[J]. Heterocycles, 2015, 91(9): 1809-1814.

[18] Mamedov IG, Eichhoff U, Maharramov AM, et al. Molecular dynamics ofcis-1-(2-hydroxy-5-methylphenyl) ethanone oxime and N-(2-hydroxy-4-methylphenyl) acetamide in solution studied by NMR spectroscopy[J]. Magn Reson Chem, 2010, 48: 671-677.

[19] Suzuki H, Furusho Y, Higashi T, et al. A novel o-aminophenol oxidase responsible for formation of the phenoxazinone chromophore of grixazone[J]. J Biol Chem, 2006, 281: 824-833.

[20] Suzuki H, Ohnishi Y, Furusho Y, et al. Novel benzene ring biosynthesis from C3 and C4 primary metabolites by two enzymes[J]. J Biol Chem, 2006, 281: 36944-36951.

[21] Omura S, Enomoto Y, Shinose M, et al. Isolation and structure of a new antibiotic viridomycin F produced by Streptomyces sp. K96-0188[J]. J Antibiotics, 1999, 52(1): 61-64.

[22] Vanga DG, Kaliappan KP. A unified strategy for the syntheses of angucyclinone antibiotics: total syntheses of tetrangulol, kanglemycin m, X-14881-E, and anhydrolandomycinone[J]. Eur J Org Chem, 2012, 11: 2250-2259.

[23] Hayakawa Y, Sohda KY, Furihata K, et al. Studies on new antitumor antibiotics, leptofuranins A, B, C and D fermentation, isolation and biological activities[J]. J Antibiotics, 1996, 27: 980-984.

[24] Kakinuma S, Ikeda H, Takada Y, et al. Production of the new antibiotic tetrahydrokalafungin by transformants of the kalafungin producer Streptomyces tanashiensis[J]. J Antibiotics, 1995, 48: 484-487.

[25] Léo PM, Morin C, Philouze C. Structure revision of medermycin/lactoquinomycin A and of related C-8 glycosylated naphthoquinones[J]. Org Lett, 2002, 16(4): 2711-2714.

[26] Chung B, Kwon OS, Shin J, et al. Antibacterial activity and mode of action of lactoquinomycin a from Streptomyces bacillaris[J]. Mar Drugs, 2021, 19: 7.

[27] Lu J, He Q, Huang LY, et al. Accumulation of a bioactive benzoisochromanequinone compound kalafungin by a wild type antitumor-medermycin-producing Streptomycete Strain[J]. PLoS One, 2015, 10(2): e0117690.

[28] Guo SQ, Hu HB, Wang W, et al. Production of antibacterial questiomycin A in metabolically engineered Pseudomonas chlororaphis HT66[J]. J Agric Food Chem, 2022, 70(25): 7742-7750.

[29] Noguchi A, Kitamura T, Onaka H, et al. A copper-containing oxidase catalyzes C-nitrosation in nitrosobenzamide biosynthesis[J]. Nat Chem Biol, 2010, 6(9): 641-643.

[30] Higashi T, Iwasaki Y, Ohnishi Y, et al. A-factor and phosphate depletion signals are transmitted to the grixazone biosynthesis genes via the pathway-specific transcriptional activator GriR[J]. J Bacteriol, 2007, 189(9): 3515-3524.

[31] Suzuki H, Ohnishi Y, Horinouchi S. GriC and griD constitute a carboxylic acid reductase involved in grixazone biosynthesis in Streptomyces griseus[J]. J Antibiotics, 2007, 60(6): 380-387.

[32] Suzuki H, Ohnishi Y, Horinouchi S. Arylamine N-acetyltransferase responsible for acetylation of 2-aminophenols in Streptomyces griseus[J]. J Bacteriol, 2007, 189(5): 2155-2159.

[33] Wang SB, Liu XH, Li B, et al. Bacteria-assisted selective photothermal therapy for precise tumor inhibition[J]. J Adv Funct Mater, 2019, 29(15): 1-12.

[34] Chen LZ, Yao L, Jiao MM, et al. Novel resveratrol-based flavonol derivatives: synthesis and anti-inflammatory activity in vitro and in vivo[J]. J Eur Med Chem, 2019, 175: 114-128.

Funding

Natural Science Funds for Distinguished Young Scholars of Anhui Province(2108085J18)

National Natural Science Foundation of China(32011540382)

National Natural Science Foundation of China(32102272)